查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1629903

全球醫療保健保護包裝市場 - 2025-2033

Global Healthcare Protective Packaging Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球醫療保健防護包裝市場規模達53億美元，預計2033年將達84億美元，2025-2033年預測期間複合年成長率為5.3%。

醫療保健防護包裝是指專門設計用於保護藥品和醫療產品免受污染、物理損壞以及光、溫度和濕度等環境因素影響的包裝解決方案。這種類型的包裝對於維持藥品、醫療器材和生物製品從製造、儲存到分銷以及醫療保健提供者和患者使用的整個供應鏈的完整性、安全性和有效性至關重要。這些特性確保醫療保健防護包裝符合監管和安全要求，並在整個供應鏈過程中保護敏感的藥品。

醫療保健保護包裝市場由多種因素推動，包括對藥品和醫療器材的需求不斷成長、包裝技術的進步以及對產品安全性和功效的日益關注。例如，根據美國國立衛生研究院的數據，2023年美國食品藥物管理局（FDA）批准了55種新藥。慢性病的增加和全球人口老化導致醫療保健支出增加，從而增加了對保護性包裝的需求，以確保藥品和醫療器材在運輸和儲存過程中的完整性。

市場動態：

驅動程式和限制

對永續發展的日益關注

對永續性的日益關注正在顯著推動醫療保健防護包裝市場的成長，預計將在預測期內推動市場的成長。消費者的偏好越來越傾向環保包裝。隨著醫療保健產品在全球範圍內使用，尤其是在已開發市場，消費者期望包裝解決方案能夠最大限度地減少對環境的影響。向可回收和可生物分解材料的轉變有助於公司滿足這些期望並遵守永續發展目標。

在泡殼包裝和單劑量容器中使用可生物分解塑膠正變得越來越普遍。 Klockner Pentaplast、Catalent 和 Berry Global 等公司透過推出和採用易於回收或堆肥的材料來引領這一轉變。

例如，2024 年 10 月，Klockner Pentaplast (kp) 推出了 kpNext MDR1，這是一種新型醫療器材包裝薄膜，將其 kpNext 品牌從藥品泡殼膜擴展到醫療器材領域。這項突破性產品旨在滿足醫療保健包裝領域對永續包裝選項不斷成長的需求。

此外，2024 年 10 月，Berry Global 推出了一系列用於醫療保健應用的澄清聚丙烯 (PP) 瓶，與傳統彩色 PET 藥瓶相比，這些瓶可提供永續性並增強產品保護。 ClariPPil 瓶非常適合各種產品，包括維生素、營養保健品、膳食補充劑、美容補充劑和非處方藥治療。 Berry 報告稱，與傳統的 PET 瓶注拉吹成型工藝相比，其新的瓶子製造技術可減少約 71% 的二氧化碳排放量。

包裝技術的進步正在促進向永續解決方案的轉變。創新包括開發可回收玻璃和永續塑膠，以及具有增強阻隔性能的包裝，以在不影響環境績效的情況下保持產品完整性。

例如，2024 年11 月，杜邦推出了具有可再生屬性(RA) 的Tyvek，這是用於醫療保健包裝的現有Tyvek 產品組合的延伸，可顯著減少碳足跡，有助於實現更永續的醫療保健包裝。透過在 Tyvek 製造所用原料的生產過程中以經過認證的生物循環原料部分取代化石燃料原料，可以減少具有可再生特性的 Tyvek 碳足跡。這是根據國際永續發展和碳認證 (ISCC PLUS) 透過品質平衡方法實現的。

嚴格的監理合規性

嚴格的監管合規性是醫療保健防護包裝市場成長的重大障礙。 FDA 的 21 CFR 第 11 部分、歐盟 MDR 和其他區域標準等監管要求對材料、標籤和文件製定了嚴格的指導方針。合規性通常需要廣泛的測試和認證流程，這對製造商來說可能既昂貴又耗時。

例如，為了滿足這些標準，包裝公司必須投資於複雜的可追溯系統、專用材料和滅菌技術，這會顯著增加包裝解決方案的成本。由於監管指南的變化，需要頻繁更新包裝設計，這使得成本結構更加複雜。

嚴格的核准流程可能會延遲新包裝解決方案推向市場的時間。獲得監管部門批准的漫長過程意味著新產品在到達消費者時往往面臨延遲，這可能會影響競爭優勢。例如，歐盟的醫療器材法規（MDR）要求製造商對包裝設計進行嚴格的測試並獲得認證，這可能需要數年時間。延長的時間可能會阻礙市場成長，因為公司必須等待推出新的合規產品。

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按包裝類型分類的片段
  • 按材料分類
  • 按產品類型分類的片段
  • 按應用程式片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 日益關注永續發展
      • 包裝不斷進步
    • 限制
      • 嚴格的監理合規性
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：醫療保健保護包裝市場（按包裝類型）

  • 初級包裝
  • 二次包裝
  • 三級包裝

第 6 章：醫療保健保護包裝市場（按材料）

  • 塑膠
  • 紙和紙板
  • 玻璃
  • 鋁

第 7 章：醫療保健保護包裝市場，依產品類型

  • 瓶子和容器
  • 吸塑包裝
  • 托盤
  • 小瓶
  • 注射器
  • 其他

第 8 章：醫療保健保護包裝市場（按應用）

  • 藥品
  • 醫療器材
  • 診斷套件
  • 營養保健品

第 9 章：醫療保健保護包裝市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 11 章：公司簡介

  • SCHOTT Pharma AG & Co. KGaA
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • Gerresheimer AG
  • Amcor plc
  • Berry Global Inc.
  • West Pharmaceutical Services, Inc.
  • Smurfit Kappa
  • Sonoco Products Company
  • WestRock Company
  • DuPont
  • Pregis LLC

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: PAC8932

The global healthcare protective packaging market reached US$ 5.3 billion in 2024 and is expected to reach US$ 8.4 billion by 2033, growing at a CAGR of 5.3% during the forecast period 2025-2033.

Healthcare protective packaging refers to packaging solutions specifically designed to safeguard pharmaceutical and medical products from contamination, physical damage and environmental factors such as light, temperature and humidity. This type of packaging is crucial in maintaining the integrity, safety and efficacy of drugs, medical devices and biologics throughout the supply chain from manufacturing and storage to distribution and use by healthcare providers and patients. These characteristics ensure that healthcare protective packaging meets regulatory and safety requirements and protects sensitive pharmaceutical products during the entire supply chain process.

The healthcare protective packaging market is driven by several factors, including the increasing demand for pharmaceuticals and medical devices, advancements in packaging technologies and growing concerns over product safety and efficacy. For instance, according to the National Institute of Health, in 2023, 55 new drugs were approved by the U.S. Food and Drug Administration (FDA). The rise in chronic diseases and the aging global population are contributing to higher healthcare spending, boosting the need for protective packaging that ensures the integrity of drugs and medical devices during transport and storage.

Market Dynamics: Drivers & Restraints

Rising focus on sustainability

The rising focus on sustainability is significantly driving the growth of the healthcare protective packaging market and is expected to drive the market over the forecast period. Consumer preferences are increasingly oriented towards eco-friendly packaging. As healthcare products are used globally, especially in developed markets, consumers expect packaging solutions that minimize environmental impact. The shift towards recyclable and biodegradable materials helps companies meet these expectations and comply with sustainability goals.

The use of biodegradable plastics for blister packs and single-dose containers is becoming more common. Companies like Klockner Pentaplast, Catalent and Berry Global are leading this transition by launching and adopting materials that can be easily recycled or composted.

For instance, in October 2024, Klockner Pentaplast (kp), launched kpNext MDR1, a new medical device packaging film that expands its kpNext brand beyond pharmaceutical blister films and into the medical device sector. This breakthrough product is designed to meet the growing demand for sustainable packaging options in healthcare packaging.

Additionally, in October 2024, Berry Global launched a range of clarified polypropylene (PP) bottles for healthcare applications, which offer sustainability and enhanced product protection compared to traditional colored PET pill bottles. ClariPPil bottles are ideal for a wide variety of products including vitamins, nutraceuticals, dietary supplements, beauty supplements and OTC treatments. Berry reports that its new manufacturing technology for the bottle delivers a reduction of approximately 71% in CO2 emissions compared to the traditional injection stretch blow molding process for PET bottles.

Advancements in packaging technologies are facilitating the shift towards sustainable solutions. Innovations include the development of recyclable glass and sustainable plastics, as well as packaging with enhanced barrier properties to maintain product integrity without compromising on environmental performance.

For instance, in November 2024, DuPont launched Tyvek with Renewable Attribution (RA), an extension of the existing portfolio of Tyvek products for healthcare packaging that offers a significantly reduced carbon footprint, helping to enable more sustainable healthcare packaging. The carbon footprint reduction for Tyvek with Renewable Attribution is enabled by the partial replacement of fossil fuel feedstock with certified bio-circular feedstock during the production of raw materials used in Tyvek manufacturing. This is achieved through the mass balance approach, in accordance with International Sustainability and Carbon Certification (ISCC PLUS).

Stringent regulatory compliance

Stringent regulatory compliance is a significant barrier to the growth of the healthcare protective packaging market. Regulatory requirements such as the FDA's 21 CFR Part 11, EU MDR, and other regional standards mandate strict guidelines for materials, labeling and documentation. Compliance often requires extensive testing and certification processes, which can be costly and time-consuming for manufacturers.

For instance, to meet these standards, packaging companies must invest in sophisticated traceability systems, specialized materials, and sterilization techniques, which can significantly increase the cost of packaging solutions. The need for frequent updates to packaging designs due to changes in regulatory guidelines further complicates the cost structure.

Stringent approval processes can delay the introduction of new packaging solutions to the market. The lengthy process of obtaining regulatory approvals means that new products often face delays in reaching consumers, which can impact competitive advantage. For instance, the EU's Medical Device Regulation (MDR) requires manufacturers to conduct rigorous testing and obtain certifications for packaging designs, which can take years. This extended timeline can hinder market growth as companies must wait to introduce new, compliant products.

Segment Analysis

The global healthcare protective packaging market is segmented based on packaging type, material, product type, application and region.

Material:

The plastic segment is expected to dominate the healthcare protective packaging market share

Plastics provide excellent barrier properties such as moisture, light and chemical resistance, which are critical for maintaining the integrity of pharmaceuticals and medical devices during storage and transport. Blister packs and pouches made from plastic are widely used for packaging tablets, capsules and syringes. Their ability to protect against contamination and damage makes them a preferred choice for pharmaceuticals and medical devices.

For instance, in October 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in partnership with pharma packaging specialist Liveo Research, this innovative solution reduces the carbon footprint of this packaging by 38% and marks a stride in environmental stewardship by eliminating the use of polyvinyl chloride (PVC).

Plastic is generally more cost-effective compared to other materials like glass and metal, making it suitable for mass production and meeting the demand for cost-efficient packaging solutions in the healthcare sector. Advancements in recycling technologies are making plastic a more sustainable option, especially with the development of recyclable and biodegradable plastics. Companies are increasingly adopting these solutions to meet regulatory requirements and consumer demand for greener products.

For instance, in October 2024, Placon released a new stock line of BargerGard TPU pouches and tip protectors. The new product line includes pouches with and without flaps and a variety of tip protectors to safeguard rough and sharp medical components, including catheters, needles, screws, drills and porous coated implants. The product line is made from thermoplastic polyurethane (TPU), a nonabrasive material that protects finished, polished, and other surfaces from damage, as well as preventing denting or scratching to devices and trays.

Geographical Analysis

North America is expected to hold a significant position in the healthcare protective packaging market share

North America has one of the most advanced healthcare infrastructures in the world, with well-established healthcare systems in countries like the United States and Canada. This infrastructure includes state-of-the-art facilities, a high rate of pharmaceutical consumption and a strong focus on medical research and development. These conditions necessitate high-quality protective packaging to maintain product integrity during distribution and storage.

For instance, according to the National Institute of Health (NIH), in 2021, overall pharmaceutical expenditures in the US grew 7.7% compared to 2020, for a total of $576.9 billion. Utilization (a 4.8% increase), price (a 1.9% increase) and new drugs (a 1.1% increase) drove this increase. For 2022, NIH expected overall prescription drug spending raised by 4.0% to 6.0%. This drug demand increases the demand for protective packaging in the region.

North America is at the forefront of adopting innovative packaging technologies, such as smart packaging and sustainable materials. Companies in this region are investing in technologies that provide enhanced barrier properties, tamper-evidence, and compliance with sustainability practices. This innovation drives demand for advanced protective packaging solutions across various healthcare sectors.

For instance, in November 2024, Nelipak Corporation, a leading global provider of packaging solutions for medical devices, diagnostic, pharmaceutical drug delivery, and other demanding applications, opened its first North American flexible packaging production site, in Winston-Salem, NC. The addition of the new production site will replicate Nelipak's existing capabilities to support growing customer demand in the Americas region.

Asia-Pacific is growing at the fastest pace in the healthcare protective packaging market

Asia Pacific economies are expanding rapidly with significant GDP growth, particularly in countries like China and India. This economic growth has led to increased healthcare spending as governments and consumers prioritize access to healthcare services. The rise in healthcare expenditure is directly boosting demand for protective packaging solutions to ensure the safety and efficacy of pharmaceuticals and medical devices.

For instance, China, as a major contributor to the market, is expected to see robust growth due to increased healthcare investments from both the government and private sectors. The demand for high-quality packaging materials to safeguard drugs and medical devices during distribution and storage is driving market expansion.

There is a growing awareness of environmental sustainability in the Asia Pacific, driving demand for eco-friendly packaging solutions. This is reflected in the adoption of recyclable plastics and biodegradable materials, particularly in countries like Japan, where stringent environmental regulations are in place.

For instance, in July 2024, the Council of Scientific and Industrial Research (CSIR) launched a National Mission on Sustainable Packaging Solutions. CSIR-National Institute for Interdisciplinary Science and Technology (NIIST), is tasked with coordinating the project that involves a consortium of eight partnering CSIR labs and industry partners.

Competitive Landscape

The major global players in the healthcare protective packaging market include SCHOTT Pharma AG & Co. KGaA, Gerresheimer AG, Amcor plc, Berry Global Inc., West Pharmaceutical Services, Inc., Smurfit Kappa, Sonoco Products Company, WestRock Company, DuPont, Pregis LLC and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global healthcare protective packaging market report delivers a detailed analysis with 70 key tables, more than 67 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Packaging Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Product Type
  • 2.6. Snippet by Application
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Focus on Sustainability
      • 3.1.1.2. Rising Advancements in Packaging
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Compliance
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Healthcare Protective Packaging Market, By Packaging Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 5.1.2. Market Attractiveness Index, By Packaging Type
  • 5.2. Primary Packaging*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Secondary Packaging
  • 5.4. Tertiary Packaging

6. Healthcare Protective Packaging Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Plastic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Paper & Paperboard
  • 6.4. Glass
  • 6.5. Aluminium

7. Healthcare Protective Packaging Market, By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Bottles and Containers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Blister Packaging
  • 7.4. Trays
  • 7.5. Vials
  • 7.6. Syringes
  • 7.7. Others

8. Healthcare Protective Packaging Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Medical Devices
  • 8.4. Diagnostic Kits
  • 8.5. Nutraceuticals

9. Healthcare Protective Packaging Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. SCHOTT Pharma AG & Co. KGaA*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Gerresheimer AG
  • 11.3. Amcor plc
  • 11.4. Berry Global Inc.
  • 11.5. West Pharmaceutical Services, Inc.
  • 11.6. Smurfit Kappa
  • 11.7. Sonoco Products Company
  • 11.8. WestRock Company
  • 11.9. DuPont
  • 11.10. Pregis LLC

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us